BiotechTube
Home/Lead Pharma/Frans van den Berg, MSc, MBA
FV

Frans van den Berg, MSc, MBA

Chief Executive Officer

Lead Pharma

Therapeutic Areas

Autoimmune DiseasesCancer

Lead Pharma Pipeline

DrugIndicationPhase
RORγt Inhibitor (SAR441169)Autoimmune Diseases (Immunology)Phase I/II
ERRα ProgramCancerPre-clinical

Leadership Team at Lead Pharma

AO
Arthur Oubrie, PhD
Chief Scientific Officer
View full Lead Pharma profile